comparemela.com

Latest Breaking News On - ஜாகோப் சாக்கோ - Page 1 : comparemela.com

Memories of some of Dundee s Middle Eastern cuisine

Memories of some of Dundee s Middle Eastern cuisine
eveningtelegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eveningtelegraph.co.uk Daily Mail and Mail on Sunday newspapers.

Experts Advocate for Community-Centered Programs to Empower APIDA Students

May 24, 2021 Share This: As the COVID-19 pandemic and thousands of incidences of anti-Asian racism and violence take their toll on Asian Pacific Islander and Desi American, or APIDA, students, faculty and staff, a team of Cal State Fullerton Asian American studies and student affairs experts developed a leadership and social justice partnership model for uplifting APIDA students and communities. Presenters Jennifer A. Yee, Jacob Chacko, Gleanne Kienzler and Vy Lê shown with attendees during their Nov. 2020 webinar. Drawing from years of collaborative work with on- and off-campus organizations, Asian American studies professor Jennifer A. Yee, inaugural Asian Pacific American Resource Center coordinator Jacob Chacko, student organizations coordinator Gleanne Kienzler and alumna Vy Lê ‘18 (B.A. ethnic studies-Asian American studies) developed a webinar detailing Cal State Fullerton’s community-centered approach to supporting students’ success over the past three dec

ORIC Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update

ORIC Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update Lead program ORIC-101 on track for two initial Phase 1b data readouts in 2021 Three IND/CTA filings for ORIC-533, -944, and -114 expected in 2021 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today reported financial results and operational updates for the quarter ended March 31, 2021. “We continue to make steady progress in advancing our robust pipeline of novel oncology candidates,” said Jacob Chacko, M.D., president and chief executive officer. “As planned, we will present preliminary safety, pharmacokinetic, and translational data, as well as early efficacy data from our ongoing Phase 1 trial of ORIC-101 in combination with nab-paclitaxel in solid tumors at the upcoming ASCO Annual Meeting. In

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.